The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis

Bryna S. M. Chow, Christine Koulis, Pooja Krishnaswamy, Ulrike M. Steckelings, Thomas Unger, Mark E. Cooper, Karin A. Jandeleit-Dahm, Terri J. Allen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1778-1790
JournalDiabetologia
Volume59
Issue number8
DOIs
Publication statusPublished - Aug 2016

Keywords

  • Angiotensin II
  • AT(2) receptor
  • Atherosclerosis
  • Compound 21
  • Diabetes

Cite this